Immunic (IMUX) EPS (Weighted Average and Diluted) Growth (3y) (2022 - 2026)
Immunic (IMUX) EPS (Weighted Average and Diluted) Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
41.33% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Immunic |
384.84 Mn |
198.21 Mn |
- |
-23.03% |
| Date | Value |
|---|
| Mar 31, 2026 |
-23.03% |
| Dec 31, 2025 |
64.91% |
| Sep 30, 2025 |
42.67% |
| Jun 30, 2025 |
34.75% |
| Mar 31, 2025 |
-50.25% |
| Dec 31, 2024 |
32.42% |
| Sep 30, 2024 |
31.90% |
| Jun 30, 2024 |
36.50% |
| Mar 31, 2024 |
43.12% |
| Dec 31, 2023 |
3.25% |
| Sep 30, 2023 |
10.02% |
| Jun 30, 2023 |
15.66% |
| Mar 31, 2023 |
9.79% |
| Mar 31, 2022 |
-90.73% |
